| 中文名称: | 3-(4'-((2-乙氧基-7-(((5-甲基-2-氧代-1,3-二氧杂环戊二烯-4-基)甲氧基)羰基)-1H-苯并[d]咪唑-1-基)甲基)-[1,1'-联苯基]-2-基)-5-氧代-5H-1,2,4-恶二唑-2-钾盐 |
| 中文别名: | 阿齐沙坦酯钾盐;阿齐沙坦酯衍生物;阿奇沙坦酯钾盐;阿齐沙坦酯甲盐;阿齐沙坦酯钾;美阿沙坦钾 |
| smiles: | [K].O=C1OC(COC(C2C3=C(N=C(N3CC3C=CC(C4C(C5NC(=O)ON=5)=CC=CC=4)=CC=3)OCC)C=CC=2)=O)=C(C)O1 |
| 英文名称: | Potassium 3-(4'-((2-ethoxy-7-(((5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy)carbonyl)-1H-benzo[d]imidazol-1-yl)methyl)-[1,1'-biphenyl]-2-yl)-5-oxo-5H-1,2,4-oxadiazol-2-ide |
| 英文别名: | Azilsartan kaMedoxoMil;1-[[2'-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester potassium salt;Azilsartan MedoxoMil PotassiuM salt;Azilsartan MedoxoMil (MonopotassiuM salt);Azilsartan MedoxoMil (MonopotassiuM);Azilsartan MedoxiMil PotassiuM;Azilsartan (medoxomil monopotassium);Azilsartan medoxomil;potassium,(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-3-[[4-[2-(5-oxo-1-oxa-2-aza-4-azanidacyclopent-2-en-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate;Azilsartan kamedoxomil (USAN);Azilsartan medoxomil monopotassium;TAK 491 monopotassium;TAK-491;UNII-WEC6I2K1FC;WEC6I2K1FC;Azilsartan Kamedoxomil (>90%);1H-Benzimidazole-7-carboxylic acid, 1-[[2′-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1′-biphenyl]-4-yl]methyl]-2-ethoxy-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester, potassium salt (9CI);Azilsartan medoxomil monopotassium salt |
| CAS号: | 863031-24-7 |
| 分子式: | C30H24KN4O8 |
| 分子量: | 607.63 |
| 密度: | |
| 熔点: | |
| 沸点: | |
| 闪点: | |
| 水溶性: | |
| 蒸气压: |
3-(4'-((2-乙氧基-7-(((5-甲基-2-氧代-1,3-二氧杂环戊二烯-4-基)甲氧基)羰基)-1H-苯并[d]咪唑-1-基)甲基)-[1,1'-联苯基]-2-基)-5-氧代-5H-1,2,4-恶二唑-2-钾盐
英文名:
Potassium 3-(4'-((2-ethoxy-7-(((5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy)carbonyl)-1H-benzo[d]imidazol-1-yl)methyl)-[1,1'-biphenyl]-2-yl)-5-oxo-5H-1,2,4-oxadiazol-2-ide
别名:阿齐沙坦酯钾盐;阿齐沙坦酯衍生物;阿奇沙坦酯钾盐;阿齐沙坦酯甲盐;阿齐沙坦酯钾;美阿沙坦钾
商品编号:R220563-250mg
规格:250mg
纯度:98%
CAS号: 863031-24-7
分子式:C30H24KN4O8
分子量:607.63
| 价格 |
¥ 168.00
(请 登录 会员查看折扣价)
|
| 货期 | 现货 |
数量
搜索质检报告(COA)
搜索MSDS
相关产品


















